Pfizer Inc.
PFE
$26.61
$0.030.11%
NYSE
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 12/31/2025 | 09/28/2025 | 06/29/2025 | 03/30/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.65B | 3.54B | -- | 2.97B | 410.00M |
| Total Depreciation and Amortization | 1.66B | 1.66B | -- | 1.61B | 1.79B |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.75B | -561.00M | -- | -327.00M | 1.60B |
| Change in Net Operating Assets | 1.59B | -36.00M | -- | -1.92B | 2.93B |
| Cash from Operations | 5.35B | 4.60B | -- | 2.34B | 6.72B |
| Capital Expenditure | -845.00M | -602.00M | -- | -564.00M | -917.00M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -6.93B | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1.63B | -1.83B | -- | 3.84B | -706.00M |
| Cash from Investing | -6.15B | -2.43B | -- | 3.27B | -1.62B |
| Total Debt Issued | 5.99B | 0.00 | -- | -- | 732.00M |
| Total Debt Repaid | -2.91B | 6.00M | -- | -2.43B | -3.45B |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -2.45B | -2.44B | -- | -2.44B | -2.38B |
| Other Financing Activities | -44.00M | -39.00M | -- | -356.00M | -14.00M |
| Cash from Financing | 596.00M | -2.48B | -- | -5.23B | -5.11B |
| Foreign Exchange rate Adjustments | 5.00M | 2.00M | -- | -7.00M | -29.00M |
| Miscellaneous Cash Flow Adjustments | -- | 2.00M | -- | -1.00M | -- |
| Net Change in Cash | -197.00M | -300.00M | -- | 374.00M | -45.00M |